Oriola-KD Corporation has completed the sale of its Healthcare Trade business to Mediq N.V.
Oriola-KD Corporation Stock Exchange Release 31 May 2010 at 1.30 p.m. The transaction of Oriola-KD Group's Healthcare Trade business to Dutch stock listed company Mediq N.V. has been completed. Mediq has paid EUR 85 million in cash for the acquisition to Oriola-KD on 31 May 2010. Oriola-KD will record a profit of approximately EUR 60 million from the sale of the business in the second quarter of 2010. The sale of the Healthcare Trade business supports Oriola-KD's strategy to focus on Pharmaceutical Wholesale and Retail businesses. The net sales of Healthcare Trade business in 2009 were EUR 145.1 million (EUR 155.2 million) and operating profit EUR 8.9 million (EUR 7.9 million). The business has currently some 440 employees in Finland, Sweden, Denmark, Estonia, Latvia and Lithuania. Changes in Oriola-KD Group's Management Team: Mr Ilari Vaalavirta, member of Oriola-KD Group's Management Team and Vice President of Healthcare Trade business will move to Mediq at time of the sale of Healthcare Trade business operations. Oriola-KD Corporation Eero Hautaniemi President and CEO Kimmo Virtanen Executive Vice President and CFO Further information: Kimmo Virtanen Executive Vice President and CFO tel. +358 (0)10 429 2069 e-mail: firstname.lastname@example.org Pellervo Hämäläinen Vice President, Communications and Investor Relations tel. +358 (0)10 429 2497 e-mail: email@example.com Distribution NASDAQ OMX Helsinki Ltd Principal media Published by: Oriola-KD Corporation Corporate Communications Orionintie 5 FI-02200 Espoo, Finland www.oriola-kd.com [HUG#1420255]